Rescue Immunosuppression With Mammalian Target of Rapamycin Inhibitor Drugs in Liver Transplantation

Transplantation Proceedings

Volumn 42, Issue 2, 2010, Pages 641-643

  Martinez J M A ^a   Pulido, L B ^a   Bellido, C B ^a   Usero, D D ^a   Aguilar, L T ^a   Moreno, J L G ^a   Artacho, G S ^a   Diez Canedo J S ^a   Gomez L M M ^a   Bravo, M A G ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CYCLOSPORIN; EVEROLIMUS; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; RAPAMYCIN; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ALOPECIA; ANEMIA; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPILEPSY; ESOPHAGITIS; FACE EDEMA; FEVER; GRAFT RECIPIENT; HERPES ZOSTER; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY FUNCTION; LEUKOPENIA; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; PARESTHESIA; PNEUMONIA; PRIORITY JOURNAL; THROMBOCYTOPENIA; THRUSH; VOMITING;

CARCINOMA, HEPATOCELLULAR; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; NEOPLASM RECURRENCE, LOCAL; PROTEIN-SERINE-THREONINE KINASES; SAFETY; SIROLIMUS;

EID: 77949433779     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.02.011     Document Type: Article

References (8)

1. Jain A., Reyes J., Kashyap R., et al. What have we learned about primary liver transplantation under tacrolimus immunosuppression?. Long term follow-up of the first 1.000 patients. Ann Surg 230 (1999) 441
2. Roque J., Rios G., Hepp J., et al. Sirolimus for rescue and recurrent acute rejection in liver transplant diabetes mellitus. Chile Rev Med 133 (2005) 1221
3. Neff G., Montalbano M., Slapak-Green G., et al. A retrospective review of sirolimus (Rapamune) therapy in orthotopic liver transplant recipients diagnosed with chronic rejection. Liver Transpl 9 (2003) 477
4. Kniepeiss D., Ibero F., Crass B., et al. Mycophenolate mofetil and sirolimus after liver transplantation. Transpl Int 16 (2003) 504
5. Nocera A., Andorno E., and Tagliamacco A. Sirolimus therapy in liver transplant patients: an initial experience at a single center. Transplant Proc 40 (2008) 1950
6. Kniepeiss D., Ibero F., and Grasser B. Mycophenolate mofetil and sirolimus after liver transplantation. Transpl Int 16 (2003) 504
7. Masetti F., Rompianesi G., and Montalti R. Effects of monotherapy everolimus on hematological parameters and iron homeostasis in de novo liver transplant recipients: preliminary results. Transplant Proc 40 (2008) 1947
8. Levy G., Schmidli H., and Punch J. Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results. Liver Transpl 12 (2006) 1571